IL1F10 and non-small cell lung carcinoma: The researchers suggest a possible underlying mechanism for the inverse correlation between intra-tumoral IL-38 expression and overall survival: elevated IL-38 in NSCLC patients may inhibit IL-36, possibly suppressing pro-inflammatory responses and promoting NSCLC progression.